Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis

Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis

Abstract Background Recently, several newer antiplatelet treatment strategies have been used in patients with coronary artery disease (CAD). Apart from the dual antiplatelet therapy (DAPT) consisting of aspirin and clopidogrel, double dose clopidogrel (DDC), triple antiplatelet therapy (TAPT) consis...

Full description

Bibliographic Details
Main Authors: Xiaojun Zhuo, Bi Zhuo, Shenyu Ouyang, Pei Niu, Mou Xiao
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Pharmacology and Toxicology
Subjects:
Double dose clopidogrel
Dual antiplatelet therapy
Ticagrelor
Prasugrel
Triple antiplatelet therapy
Coronary artery disease
Online Access:http://link.springer.com/article/10.1186/s40360-018-0247-9

Internet

http://link.springer.com/article/10.1186/s40360-018-0247-9

Similar Items